Use "Flozins" Second-Line for Type 2 Diabetes

The American Diabetes Assn will endorse more drug combo choices for patients with type 2 diabetes.

Metformin plus lifestyle changes will remain first-line...but most type 2s will need 2 or more meds to reach glycemic goals.

SGLT2 inhibitors or "flozins" (Invokana, etc) will be a new second-line choice...along with sulfonylureas, glitazones (Actos, etc), gliptins (Januvia, etc), GLP-1 agonists (Victoza, etc), and insulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote